RSCI broke above its upper Bollinger Band on December 06, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 28 similar instances where the stock broke above the upper band. In of the 28 cases the stock fell afterwards. This puts the odds of success at .
The Aroon Indicator for RSCI entered a downward trend on December 18, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where RSCI's RSI Indicator exited the oversold zone, of 18 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 49 cases where RSCI's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on December 18, 2024. You may want to consider a long position or call options on RSCI as a result. In of 61 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for RSCI just turned positive on November 12, 2024. Looking at past instances where RSCI's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .
RSCI moved above its 50-day moving average on December 18, 2024 date and that indicates a change from a downward trend to an upward trend.
Following a +3 3-day Advance, the price is estimated to grow further. Considering data from situations where RSCI advanced for three days, in of 33 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (57.958). P/E Ratio (0.000) is within average values for comparable stocks, (89.727). RSCI's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.947). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (19.472).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. RSCI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RSCI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.
Industry PharmaceuticalsOther
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
WLGCX | 24.31 | -0.65 | -2.60% |
Delaware Ivy Large Cap Growth Fund C | |||
RYSEX | 15.25 | -0.45 | -2.87% |
Royce Small-Cap Special Equity Invmt | |||
HAVLX | 22.95 | -0.69 | -2.92% |
Harbor Large Cap Value Instl | |||
BRLGX | 38.04 | -1.27 | -3.23% |
American Beacon Man Lg Cp Growth R5 | |||
FNPIX | 41.29 | -1.98 | -4.58% |
ProFunds Financials UltraSector Inv |
A.I.dvisor tells us that RSCI and ETST have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RSCI and ETST's prices will move in lockstep.
Ticker / NAME | Correlation To RSCI | 1D Price Change % | ||
---|---|---|---|---|
RSCI | 100% | +47.81% | ||
ETST - RSCI | 22% Poorly correlated | +8.33% | ||
RAFA - RSCI | 7% Poorly correlated | -10.87% | ||
SGIOF - RSCI | 6% Poorly correlated | N/A | ||
PCYN - RSCI | 5% Poorly correlated | N/A | ||
TEVJF - RSCI | 5% Poorly correlated | N/A | ||
More |
Ticker / NAME | Correlation To RSCI | 1D Price Change % |
---|---|---|
RSCI | 100% | +47.81% |
Pharmaceuticals: Other industry (226 stocks) | 2% Poorly correlated | -1.31% |
Pharmaceuticals industry (308 stocks) | -0% Poorly correlated | -1.36% |